The Journal of
Clinical Psychiatry

Addiction

Letter to the Editor October 15, 1996

Misuse of Naltrexone

Michael O. Measom, MD

J Clin Psychiatry 1996;57(10):489-490

Article Abstract

Letter to the Editor

Sir: Abuse of naltrexone when used for the treatment ofopioid dependence and during treatment of posttraumaticstress disorder (PTSD) has been noted. Following is a case ofmisuse of naltrexone when utilized solely for the treatment ofalcohol dependence.

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 86 • 2025 • Number 1

Read the Current Issue

Original Research

Psychological Support in Psychedelic Therapy

Original Research

Long-Term Safety and Efficacy of Esmethadone in MDD

Original Research

Suicidal Behaviors and Obstructive Sleep Apnea

Editorial

A Collaborative Endeavor

Brief Report

Sex Differences in PTSD among US Military Veterans

Clinical and Practical Psychopharmacology

Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes in Children and Young Adults

View current Issue

Related Articles

Detecting Misuse of Prescription Opioids

Letter to the Editor

Detecting Misuse of Prescription Opioids

October 21, 2024

The authors discuss the difficulty in screening for opioid misuse and the need for clinicians to gain confidence in initiating difficult discussions with patients on long-term opioid treatment.

Vania Modesto-Lowe , Alyssa Crispino , Michael Salley

Harm Reduction in Adolescent Inhalant Use

Letter to the Editor

Harm Reduction in Adolescent Inhalant Use

October 15, 2024

The authors discuss harm reduction efforts targeting inhalant use in the adolescent population.

Vania Modesto-Lowe , Roseane Rodrigues , Deanna Sgambato

Zeroing in on Xylazine

Letter to the Editor

Zeroing in on Xylazine

August 15, 2024

Dr Kaur and colleagues discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.

Jasleen Kaur , Megan Nosol , Vania Modesto-Lowe